Sigma Healthcare, TechnologyOne, South32 shares: Buy, hold, or sell?

Experts provide their views on three big names in the marketplace today.

| More on:
A young woman wearing a red and white striped t-shirt puts her hand to her chin and looks sideways as she wonders whether to buy ASX shares

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

S&P/ASX 200 Index (ASX: XJO) shares closed higher on Tuesday, up 0.92% to 8,941.6 points.

In this article, three experts provide their views on three big names in the marketplace today.

South32 Ltd (ASX: S32)

The South32 share price closed at $4.50 on Tuesday, up 2.51%, after hitting a 52-week high of $4.54.

Morgans has a buy rating on this diversified ASX 200 mining share with a 12-month price target of $5.

The broker increased its price target from $4.50 after South32 released its 2Q FY26 update last week.

Morgans said South32 achieved a modest beat on consensus expectations for operations, supported by strong alumina and silver output.

The broker commented:

FY26 guidance on operated assets unchanged, Brazil Aluminium under review.

We have applied updated house precious metal forecasts to our estimates.

Post-Illawarra divestment, S32 is ~90% base metal producer with limited execution risk (ex-Hermosa) and enjoying a healthy (and material) upgrade cycle from copper, aluminium and silver prices.

Positioned to benefit from the upcycle, we maintain our BUY rating with a A$5.00 Target Price (was A$4.30).

Sigma Healthcare Ltd (ASX: SIG)

The Sigma Healthcare share price closed at $3.09 on Tuesday, up 0.98%.

On The Bull this week, Remo Greco from Sanlam Private Wealth revealed a hold rating on this ASX 200 healthcare share.

Greco explained:

At its recent annual general meeting, this retail pharmacy franchisor and pharmaceutical wholesaler announced it would continue to roll out new stores domestically and internationally. It would revitalise the Amcal and Discount Drug Store brands.

Chemist Warehouse network sales were up 17.9 per cent in the first quarter of 2026 and like-for-like sales were up 14.7 per cent.

So far, SIG appears to be delivering on its lofty expectations.

Technology One Ltd (ASX: TNE)

The Technology One share price closed at $27.11, down 0.26% today.

Stuart Bromley from Medallion Financial Group has a hold rating on this ASX 200 tech share.

Bromley described the company as a high quality, recurring revenue software business with product depth and customer loyalty.

However, he noted the share price pullback, with Technology One losing 31% of its value over six months.

Bromley commented:

Near term momentum has been lacklustre, with growth rates moderating.

The share price pull-back leaves TNE as a hold, or even presents an opportunity to accumulate a longer term powerhouse during a period of sector- wide re-pricing.

TNE remains a structural leader in enterprise applications and we don't see this market strength ceasing any time soon.

Motley Fool contributor Bronwyn Allen has positions in South32. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Technology One. The Motley Fool Australia has recommended Technology One. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Businessman working and using Digital Tablet new business project finance investment at coffee cafe.
Broker Notes

This ASX 200 stock has a 'strong runway' and offers a 24% total return

18% upside and a 6% dividend yield could be on offer with this stock according to Bell Potter.

Read more »

Multiracial happy young people stacking hands outside - University students hugging in college campus - Youth community concept with guys and girls standing together supporting each other.
Broker Notes

Bell Potter names more of the best ASX shares to buy in February

The broker has good things to say about these shares. Let's find out why.

Read more »

Ecstatic man giving a fist pump in an office hallway.
Broker Notes

Bell Potter says these ASX 200 stocks are buys with 20%+ upside

The broker remains positive on these blue chips following their results releases.

Read more »

A woman with a mobile phone in her hand looks sceptical with a puzzled expression on her face with an eyebrow raised and pursed lips.
Broker Notes

Buy, hold, sell: Bubs, Origin Energy, 4D Medical shares

Experts reveal their ratings on three ASX shares in the consumer staples, utilities, and healthcare sectors.

Read more »

A man holding a cup of coffee puts his thumb up and smiles while at laptop.
Broker Notes

Morgans upgrades 3 ASX shares to buy ratings

The broker is tipping these buy-rated shares to rise 20% to 75%.

Read more »

Red buy button on an apple keyboard with a finger on it representing asx tech shares to buy today
Broker Notes

3 ASX 200 shares to buy: experts

Experts reveal three ASX 200 shares with buy ratings, and why they recommend investing in them.

Read more »

Two mining workers on a laptop at a mine site.
Resources Shares

3 ASX mining shares to sell: experts

ASX mining shares are a popular investment amid rising commodity prices, but experts recommend selling these producers.

Read more »

Two businesspeople walk together in an office, smiling as they enjoy a good business relationship.
Broker Notes

This ASX 200 share could rise 30% and pay a 5% dividend yield

Bell Potter sees this stock as a top pick for Aussie investors in 2026.

Read more »